Skip to main content
Clinical Trials/ISRCTN15119603
ISRCTN15119603CompletedUnknown

Investigating the effects of tryptophan modulation on attention and impulsivity in adults with and without Attention Deficit Hyperactivity Disorder: A double blind randomised controlled trial

King's College London0 sites144 target enrollmentStarted: May 3, 2023Last updated:
Conditions

Trial Snapshot

Phase
Unknown
Status
Completed
Enrollment
144

Study Overview

Brief Summary

2023 Results article in https://pubmed.ncbi.nlm.nih.gov/38033150/ (added 05/12/2023)

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • All participants:
  • 1. Adults aged 18-35 years
  • Healthy control participants (HC):
  • 2. No diagnosis of ADHD and score on the Adult ADHD Self-Report Scale below the threshold indicative of ADHD.
  • 3. Existing current diagnosis of ADHD and score on the Adult ADHD Self-Report Scale above the threshold indicative of ADHD.
  • 4. Either not receiving ADHD medication and have not received any for a period of at least 3 months or receiving medication for ADHD (psychostimulant or non-stimulant) and adhering to this with a rate of at least 70%.

Exclusion Criteria

  • 1. Gluten or lactose intolerance, as participants will be asked to ingest a whey protein drink
  • 2. Current or past diagnosis of nutritional, psychiatric (excluding ADHD) or neurological illnesses
  • 3. Being pregnant/breastfeeding
  • 4. Being a smoker (including e-cigarettes)
  • 5. Currently taking medication known to affect the serotonergic system such as antidepressants
  • 6. Learning disabilities
  • 7. Following a restrictive diet (e.g. keto), as this might interfere with the experiment

Investigators

Similar Trials

Investigating the effects of acute... | Clinical Trial